From Delta State U-Nigeria: Ethics of clinical trials in Nigeria

Niger Med J. 2014 May;55(3):188-94. doi: 10.4103/0300-1652.132035.

Ethics of clinical trials in Nigeria.

Okonta PI.

Author information

• Department of Obstetrics and Gynaecology, Delta State University, Abraka, Delta, Nigeria.

Abstract

The conduct of clinical trials for the development and licensing of drugs is a very important aspect of healthcare. Drug research, development and promotion have grown to a multi-billion dollar global business. Like all areas of human endeavour involving generation and control of huge financial resources, it could be subject to deviant behaviour, sharp business practices and unethical practices. The main objective of this review is to highlight potential ethical challenges in the conduct of clinical trials in Nigeria and outline ways in which these can be avoided. Current international and national regulatory and ethical guidelines are reviewed to illustrate the requirements for ethical conduct of clinical trials. Past experiences of unethical conduct of clinical trials especially in developing countries along with the increasing globalisation of research makes it imperative that all players should be aware of the ethical challenges in clinical trials and the benchmarks for ethical conduct of clinical research in Nigeria.